Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 77,467 | 68,129 | 52,511 | 50,410 | 50,025 |
| Cost of Goods | -4,116 | 6,366 | 5,577 | 4,812 | 6,155 |
| Gross Profit | 81,583 | 61,763 | 46,934 | 45,598 | 43,870 |
| Operating Expenses | 79,530 | 53,245 | 50,512 | 49,706 | 44,352 |
| Operating Income | 1,937 | 8,884 | -3,001 | -3,296 | -327 |
| Interest Expense | 2,415 | 2,355 | 2,238 | 2,702 | 2,820 |
| Other Income | 532 | -34 | 397 | 1,036 | 610 |
| Pre-tax Income | 54 | 6,495 | -4,842 | -4,962 | -2,537 |
| Income Tax | 34 | -3,170 | 78 | 81 | 88 |
| Net Income Continuous | 20 | 9,665 | -4,920 | -5,043 | -2,625 |
| Net Income | $20 | $9,665 | $-4,920 | $-5,043 | $-2,625 |
| EPS Basic Total Ops | 0.00 | 0.10 | -0.05 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | 0.10 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Total Ops | 0.00 | 0.10 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | 0.10 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.10 | -0.05 | -0.05 | -0.03 |
| EBITDA(a) | $3,052 | $9,952 | $-2,176 | $-2,628 | $708 |